مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

135
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

97
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation? (Invited Commentary)

Pages

  148-149

Keywords

Not Registered.

Abstract

 One of the most significant findings of the 1990s was the discovery of the BRCA gene mutation, which was a major advancement in the prevention of breast cancer. Since the BRCA breakthrough, screening for breast cancer susceptibility genes has become of great interest to high-risk patients and their family members. 1, 2 BRCA1 and BRCA2 are two major genes responsible for about 5% to 10% of all breast cancer cases and 10% to 18% of ovarian cancer cases. Carriers of BRCA1/2 mutation could have an elevated risk of 69% to 72% for breast cancer compared with the average-risk women (12%)...

Cites

  • No record.
  • References

    Cite

    APA: Copy

    EBRAHIMI, ELMIRA, & SHIRKOOHI, REZA. (2018). What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation? (Invited Commentary). ARCHIVES OF BREAST CANCER, 5(4), 148-149. SID. https://sid.ir/paper/349110/en

    Vancouver: Copy

    EBRAHIMI ELMIRA, SHIRKOOHI REZA. What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation? (Invited Commentary). ARCHIVES OF BREAST CANCER[Internet]. 2018;5(4):148-149. Available from: https://sid.ir/paper/349110/en

    IEEE: Copy

    ELMIRA EBRAHIMI, and REZA SHIRKOOHI, “What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation? (Invited Commentary),” ARCHIVES OF BREAST CANCER, vol. 5, no. 4, pp. 148–149, 2018, [Online]. Available: https://sid.ir/paper/349110/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button